Prof. Dr. MUSTAFA SERTAÇ YAZICI

Yayın Ağı

Makaleler 79

1. Effect of Bacillus Calmette-Guerin Instillation Timing on Oncological Survivals After Transurethral Resection of Bladder Tumor

Cetin T., Bolat D., Akgul M., YAZICI M. S., Aslan G., Akan S., et al.

UROLOGY , ss.126-132, 2025 (SCI-Expanded, Scopus)

2. Lifestyle recommendations and pelvic floor muscle training with Knack maneuver for post-prostatectomy urinary incontinence: a randomized controlled trial.

Atabey Gerlegiz E. N., Akbayrak T., Gursen C., Yazıcı S., Mangir N., Akdoğan B., et al.

SUPPORTIVE CARE IN CANCER , sa.2, ss.132-145, 2025 (SCI-Expanded, Scopus)

3. A new parameter to increase the predictive value of multiparametric prostate magnetic resonance imaging for clinically significant fi cant prostate cancer in targeted biopsies: lesion density

ŞAHİN B., Celik S., Sozen S., TÜRKERİ L., ASLAN G., YAZICI M. S., et al.

PROSTATE INTERNATIONAL , cilt.12, sa.3, ss.145-150, 2024 (SCI-Expanded, Scopus)

4. Lessons For COVID-19 Era: Impact of Delays in Surgery on Biochemical Recurrence-Free Survival and Adverse Oncological Outcomes in Patients with Prostate Cancer

ŞAHİN B., BOZKURT O., Sozen S., Ozen H., AKDOĞAN B., ASLAN G., et al.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.23, sa.2, ss.43-49, 2024 (ESCI, TRDizin)

5. The Cancer of the Bladder Risk Assessment Score and Mortality-Survival Relationship Among Patients Who Have Undergone Radical Cystectomy in the Turkish Urooncology Association Database

Tavukcu H. H., Tinay I., Izol V., BALTACI S., TEKE K., SÜER E., et al.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.23, sa.2, ss.56-62, 2024 (ESCI, TRDizin)

6. Long-term follow-up results of multiparametric prostate MRI and the prognostic value of PI-RADS: a single-center retrospective cohort study

ÖNDER Ö., Ayva M., YARAŞIR Y., GÜRLER V., YAZICI M. S., AKDOĞAN B., et al.

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY , cilt.30, sa.3, ss.139-151, 2024 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

7. The Effect of Perineural Invasion on Biochemical Recurrence-free Survival Following Nerve-sparing Radical Prostatectomy

Kumsar S., ASLAN G., Suer E., AKDOĞAN B., Sozen S., Gülşen M., et al.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.23, sa.1, ss.1-5, 2024 (ESCI, TRDizin) Sürdürülebilir Kalkınma

8. Do Subgroup Evaluations Provide Additional Contributions to Biochemical Recurrence in Grade Group 4 and 5 Patients? A Multicenter Study by the Turkish Urooncology Association Prostate Cancer Working Group

Cetin T., Celik S., SÜER E., Sozen S., Izol V., AKDOĞAN B., et al.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.23, sa.1, ss.10-15, 2024 (ESCI, TRDizin) Sürdürülebilir Kalkınma

9. Can We Predict Recurrence of pT1-2 Renal Cell Carcinoma?

Uecer O., Mueezzinoglu T., Aslan G., Sueer E., BALTACI S., Izol V., et al.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.23, sa.1, ss.6-9, 2024 (ESCI, TRDizin) Sürdürülebilir Kalkınma

10. Comparison of Health-Related Quality of Life Changes in Prostate Cancer Patients Undergoing Laparoscopic versus Robotic-Assisted Laparoscopic Radical Prostatectomy: A Systematic review

YAZICI M. S., TONYALI Ş.

Urology journal , cilt.21, sa.1, ss.14-19, 2024 (SCI-Expanded, Scopus)

11. Comparison of rigid and elastic registration methods in software-based targeted prostate biopsy: a multicenter cohort study

ÇETİN S., Celik S., KOPARAL M. Y., ASLAN G., YAZICI M. S., ŞAHİN B., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , sa.6, ss.1327-1334, 2024 (SCI-Expanded, Scopus, TRDizin)

12. Oncological Outcomes of Chromophobe Versus Clear Cell Renal Cell Carcinoma: Results from A Contemporary Turkish Patient Cohort

Cetin T., Celik S., Sozen S., Ozen H., AKDOĞAN B., ASLAN G., et al.

UROLOGY JOURNAL , cilt.21, sa.5, ss.320-324, 2024 (SCI-Expanded, Scopus)

13. What is the Optimal Time Period for Postponing Nephrectomy in Patients with Renal Cell Carcinoma of Various Stages?

Celik S., Tinay I., Sozen S., Ozen H., AKDOĞAN B., Aslan G., et al.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.22, sa.4, ss.150-155, 2023 (ESCI, TRDizin) Sürdürülebilir Kalkınma

14. Determination of the PSA Cut-off Value to Predict the Clinically Significant Prostate Cancer in Patients with Positive Multiparametric MRI: A Population-based Study

KIZILAY F., Celik S., Narter F., Sozen S., Ozen H., AKDOĞAN B., et al.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.22, sa.3, ss.100-105, 2023 (ESCI, TRDizin) Sürdürülebilir Kalkınma

15. Risk Factors for Complications in Simple Nephrectomy: 17-Year Results from Single Institution

ARTYKOV M., HABERAL H. B., BAHADIR Ö. F., GÜDELOĞLU A., AKDOĞAN B., AKI F. T., et al.

Journal of Urological Surgery , cilt.10, sa.2, ss.139-146, 2023 (TRDizin)

16. Risk Factors for Testicular Cancer: Environment, Genes and Infections—Is It All?

YAZICI M. S., Del Biondo D., Napodano G., Grillo M., Calace F. P., Prezioso D., et al.

Medicina (Lithuania) , cilt.59, sa.4, 2023 (SCI-Expanded, Scopus)

17. Hodgkin Lymphoma in Patients Receiving Clozapine Treatment: 2 Case Reports and Literature Review.

Doǧan M. K., Erdoǧan N. O., ERTUĞRUL A., Yaǧcioǧlu A. E., YAZICI M. S.

Journal of clinical psychopharmacology , cilt.43, sa.2, ss.180-183, 2023 (SCI-Expanded, Scopus)

18. The Robotic Intracorporeal Vesuvian Orthotopic Neobladder (VON)—A New Technique for Continent Urinary Diversion: Initial Experience and Description of the Technique

Del Biondo D., Napodano G., Barone B., Iacone M., Grillo M., Ottaviano N., et al.

Applied Sciences (Switzerland) , cilt.12, sa.22, 2022 (SCI-Expanded, Scopus)

19. Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case series El valproato, la obesidad y otras causas de metabolismo deficiente de la clozapina en el contexto de una titulación rápida de las dosis pueden explicar la miocarditis inducida por clozapina: un nuevo análisis de una serie de casos turca

ERTUĞRUL A., ANIL YAĞCIOĞLU A. E., Ağaoğlu E., Karakaşlı A. A., AK S., YAZICI M. S., et al.

Revista de Psiquiatria y Salud Mental , cilt.15, sa.4, ss.281-286, 2022 (SCI-Expanded, SSCI, Scopus)

20. A New Technique for Continent Urinary Diversion: Initial Experience and Description of the Technique

Biondo D. D., Napodano G., Di Giacomo F., Di Domenico D. D., Feleppa B., YAZICI M. S., et al.

Urology Journal , cilt.19, sa.4, ss.300-306, 2022 (SCI-Expanded, Scopus)

21. A NEW SCREENING TOOL FOR PSORIATIC ARTHRITIS IN PSORIASIS PATIENTS: TURPAS

AYAN G., Hatemi G., Can G., Bektas M., Ozdede A., Akdogan N., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1597-1598, 2022 (SCI-Expanded, Scopus)

22. Safety of Minimally Invasive Surgical Techniques in Large Adrenal Lesions: A Single-Centre Study

YAZICI M. S., Artykov M., HABERAL H. B., Mammadaliyev T., GÜDELOĞLU A., BİLEN C. Y.

Journal of the College of Physicians and Surgeons Pakistan , cilt.32, sa.5, ss.565-569, 2022 (SCI-Expanded, Scopus)

23. Comparison of clamping strategies in minimally invasive partial nephrectomy for cT1 tumors

Artykov M., HABERAL H. B., KAHRAMAN O., GÜDELOĞLU A., YAZICI M. S., BİLEN C. Y.

MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES , cilt.31, sa.4, ss.609-614, 2022 (SCI-Expanded, Scopus)

24. Impact of Variant Histology on Clinical and Pathological Outcomes in Patients with the Upper Urinary Tract Urothelial Carcinoma

Artykov M., HABERAL H. B., ALTAN M., KÖSEMEHMETOĞLU K., YAZICI M. S., Ozen H., et al.

MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL , cilt.56, sa.2, ss.284-290, 2022 (ESCI, TRDizin)

25. Pathology associated with adherent perirenal fat and its clinical effect

CEYHAN E., İLERİ F., AKI F. T., YAZICI M. S., KARÇAALTINCABA M., Ertoy Baydar D., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.75, sa.10, 2021 (SCI-Expanded, Scopus)

26. The SPARE score reliably predicts the conversion from open partial to radical nephrectomy

HABERAL H. B., ÇITAMAK B., ALTAN M., YAZICI M. S., AKDOĞAN B., Ozen H., et al.

CROATIAN MEDICAL JOURNAL , cilt.62, sa.4, ss.464-471, 2021 (SCI-Expanded, Scopus)

27. Predictors of ISUP score upgrade in patients with low-risk prostate cancer.

Haberal H., Artykov M., Hazir B., Citamak B., Altan M., Yazici S., et al.

Tumori , cilt.107, ss.254-260, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. Comparison of TRUS and combined MRI-targeted plus systematic prostate biopsy for the concordance between biopsy and radical prostatectomy pathology.

ASLAN G., Celik S., Sozen S., AKDOĞAN B., İZOL V., BİLEN C. Y., et al.

International journal of clinical practice , cilt.75, 2021 (SCI-Expanded, Scopus)

29. Acute Ischemic Stroke Following Chemotherapy for Malignant Mixed Testicular Germ Cell Tumour: Does Cisplatin Play a Role?

HAZIR B., Artykov M., AŞCI A., HABERAL H. B., YAZICI M. S.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.20, sa.1, ss.67-70, 2021 (ESCI, TRDizin)

30. Determination of risk factors for progression in patients with viable tumor at post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors

ALTAN M., HABERAL H. B., AŞCI A., GÜDELOĞLU A., DOĞRUL A. B., YAZICI M. S., et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , cilt.26, sa.1, ss.186-191, 2021 (SCI-Expanded, Scopus)

31. Minimally Invasive Partial Nephrectomy in the Era of Robotic Surgery

HABERAL H. B., Artykov M., GÜDELOĞLU A., YAZICI M. S., BİLEN C. Y.

MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL , cilt.55, sa.2, ss.167-172, 2021 (ESCI, TRDizin)

32. Robotic Seminal Vesicle Surgery: The Key Steps

Artykov M., HABERAL H. B., GÜDELOĞLU A., YAZICI M. S., BİLEN C. Y.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.19, sa.4, ss.218-219, 2020 (ESCI, TRDizin)

33. Clinicopathological predictors of positive Ga-68-PSMA-11 PET/CT in PSA-only recurrence of localized prostate cancer following definitive therapy

Aydin A. M., Haberal B., Artykov M., BİLEN C. Y., Yazici S.

ANNALS OF NUCLEAR MEDICINE , cilt.33, sa.5, ss.326-332, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Cystectomy and urinary diversion improves health-related quality of life in female patients with non-malignant urologic diseases

TONYALI Ş., YAZICI M. S., Aydogan B., ERGEN A.

KUWAIT MEDICAL JOURNAL , cilt.51, sa.1, ss.33-38, 2019 (SCI-Expanded, Scopus)

35. Urinary and Fecal Diversion Following Pelvic Exenteration: Comparison of Double-Barrelled and Plain Wet Colostomy

Yazici S., Tonyali S., Bozaci A. C., Haberal H. B., Hamaloglu E., Ozen H.

UROLOGY JOURNAL , cilt.15, sa.5, ss.290-294, 2018 (SCI-Expanded, Scopus)

36. The Safety and Efficacy of Adjuvant Hemostatic Agents During Laparoscopic Nephron-Sparing Surgery: Comparison of Tachosil and Floseal Versus No Hemostatic Agents

Tonyali S., Koni A., Yazici S., BİLEN C. Y.

UROLOGY JOURNAL , cilt.15, sa.1, ss.21-25, 2018 (SCI-Expanded, Scopus)

37. Percutaneous Nephrolithotomy in Solitary Kidneys: 17 Years of Experience

Haberal H. B., Citamak B., Bozaci A. C., YAZICI M. S., AKI F. T., BİLEN C. Y.

UROLOGY , cilt.109, ss.55-59, 2017 (SCI-Expanded, Scopus)

38. A Rare Presentation of Germ Cell Neoplasia: Persistant Mullerian Duct Syndrome

BEKSAÇ A. T., DÖNMEZ M. İ., Aydin C., BAYDAR D., YAZICI M. S., ERGEN A., et al.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.16, sa.3, ss.101-104, 2017 (ESCI, TRDizin)

39. Squamous Metaplasia and Its Management in Non-malignant Bladder Diseases

TONYALI Ş., HABERAL H. B., YAZICI M. S., BAYDAR D., ERGEN A.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.16, sa.2, ss.38-41, 2017 (ESCI, TRDizin)

40. Survival following laparoscopic adrenalectomy for solitary metastasis of lung cancer

Tonyali S., HABERAL H. B., Yazici S., ERMAN M., KAYNAROĞLU Z. V., BİLEN C. Y.

INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.48, sa.11, ss.1803-1809, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. The Ewing's Sarcoma Family of Tumors of Urinary Bladder: A Case Report and Review of the Literature

Tonyali S., Yazici S., Yesilirmak A., ERGEN A.

BALKAN MEDICAL JOURNAL , cilt.33, sa.4, ss.462-466, 2016 (SCI-Expanded, Scopus, TRDizin)

42. Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?

Tonyali S., Yazici S.

INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.48, sa.5, ss.671-680, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Predictors of prostate cancer in ultrasound-guided transperineal saturation biopsy in Turkish men with multiple prior negative biopsies

YAZICI S., KIZILOZ H., Bozaci A. C., BAYDAR D. E., DEL BIONDO D., OZEN H.

UROLOGIA JOURNAL , cilt.83, sa.2, ss.71-76, 2016 (ESCI, Scopus) Sürdürülebilir Kalkınma

44. Which Patients Should Undergo Immediate or Deferred Cystectomy in Non-Muscle Invazive Bladder Cancer? Evaluation of Selection Criteria

Tonyali S., YAZICI M. S.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.15, sa.1, ss.26-30, 2016 (ESCI, TRDizin)

45. The Pathologic Point of View of Laparoscopic Adrenalectomy in the Era of Radiologic Imaging: A Multicenter Retrospective Study

Tonyali S., Atac F., Eroglu U., Yazici S., Ozden E., Sozen S., et al.

UROLOGIA INTERNATIONALIS , cilt.97, sa.2, ss.173-178, 2016 (SCI-Expanded, Scopus)

46. Minimal Invasive Management of Small Renal Masses: State of Art and New Trends

Tonyali S., Yazici S.

JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE , cilt.6, ss.896-900, 2015 (ESCI, TRDizin) Sürdürülebilir Kalkınma

47. Laparoscopic Upper Pole Heminephrectomy in Adults for Treatment of Duplex Kidneys

DÖNMEZ M. İ., YAZICI M. S., Abat D., KARA Ö., BAYAZIT Y., BİLEN C. Y.

UROLOGY JOURNAL , cilt.12, sa.2, ss.2074-2077, 2015 (SCI-Expanded, Scopus)

48. The developments in paradigm of prostate cancer in recent years

YAZICI M. S., Kiziloz H., Ozen H.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.13, sa.1, ss.1-7, 2014 (ESCI, TRDizin) Sürdürülebilir Kalkınma

49. Salvage radical prostatectomy for locally recurrent prostate cancer following primary radiotherapy

Bozaci A. C., YAZICI M. S.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.12, sa.2, ss.137-141, 2013 (ESCI, TRDizin) Sürdürülebilir Kalkınma

50. A Preoperative Prognostic Model Predicting Recurrence-free Survival for Patients With Kidney Cancer

Yaycioglu O., Eskicorapci S., KARABULUT E., Soyupak B., Gogus C., Divrik T., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , cilt.43, sa.1, ss.63-68, 2013 (SCI-Expanded, Scopus)

51. Neoadjuvant targeted therapy in renal cell carcinoma

YAZICI M. S., Kiziloz H., Ozen H.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.11, sa.3, ss.240-245, 2012 (ESCI, TRDizin) Sürdürülebilir Kalkınma

52. ADVANTAGES USING ADJUVANT HEMOSTATIC AGENTS IN LAPAROSCOPIC PARTIAL NEPHRECTOMY

KONİ A., ÖZDEMİR B., GÜDELOĞLU A., YAZICI M. S., Inci K., BİLEN C. Y.

JOURNAL OF ENDOUROLOGY , cilt.26, 2012 (SCI-Expanded, Scopus)

53. Does radiologic stage predict pathologic stage and cancer specific survival according to revised 7th TNM version in renal cancer?

Acar I. C., Eskicorapci S. Y., Yaycioglu O., Divrik T., Yazici S., DEMİRTAŞ A., et al.

EUROPEAN UROLOGY SUPPLEMENTS , cilt.11, sa.1, 2012 (SCI-Expanded)

54. Expression of glutathione-S-transferases isoenzymes and p53 in exfoliated human bladder cancer cells

Oguztuzun S., Sezgin Y., Yazici S., Firat P., Ozhavzali M., Ozen H.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , cilt.29, sa.5, ss.538-544, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. Recent advancements in the targeted therapy of metastatic kidney cancer

YAZICI M. S., Kiziloz H., Ozen H.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.10, sa.3, ss.41-51, 2011 (ESCI, TRDizin) Sürdürülebilir Kalkınma

56. PSA: past, today and tomorrow

Gunay L. M., YAZICI M. S., Ozen H.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.10, sa.2, ss.5-10, 2011 (ESCI, TRDizin)

57. A PREOPERATIVE PROGNOSTIC MODEL PREDICTING RECURRENCE FREE SURVIVAL FOR PATIENTS WITH KIDNEY CANCER: A MULTI-CENTER STUDY BY THE SOCIETY OF UROONCOLOGY

Yaycioglu O., Eskicorapci S., Karabulut E., Soyupak B., Gogus C., Divrik T., et al.

JOURNAL OF UROLOGY , cilt.185, sa.4, 2011 (SCI-Expanded, Scopus)

58. Renal cell carcinoma with inferior vena cava thrombus: The Hacettepe experience

Yazici S., Inci K., BİLEN C. Y., GÜDELOĞLU A., AKDOĞAN B., Ertoy D., et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS , cilt.28, sa.6, ss.603-609, 2010 (SCI-Expanded, Scopus)

59. ROBOTIC RADIOSURGERY IN PROSTATE ADENOCARCINOMA: INITIAL THERAPEUTIC RESULTS AND QUALITY OF LIFE ASSESMENT

Akyol F., Ozyigit G., Sanli Y. T., Cengiz M., Akdogan B., YAZICI M. S., et al.

RADIOTHERAPY AND ONCOLOGY , cilt.96, 2010 (SCI-Expanded, Scopus)

60. Proteasome Inhibitor Bortezomib Increases Radiation Sensitivity in Androgen Independent Human Prostate Cancer Cells

Goktas S., Baran Y., Ural A. U., Yazici S., Aydur E., Basal S., et al.

UROLOGY , cilt.75, sa.4, ss.793-798, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

61. Renal Artery Pseudoaneurysm: Complication of Minimally Invasive Kidney Surgery

Inci K., Cil B., Yazici S., PEYNİRCİOĞLU B., Tan B., Sahin A., et al.

JOURNAL OF ENDOUROLOGY , cilt.24, sa.1, ss.149-154, 2010 (SCI-Expanded, Scopus)

62. Management of High-Risk Localised Prostate Cancer

Ozen H., Yazici S., Inci K.

EUROPEAN UROLOGY SUPPLEMENTS , cilt.8, sa.5, ss.439-447, 2009 (SCI-Expanded, Scopus)

63. Radical Prostatectomy After Previous Prostate Surgery: Effects on Surgical Difficulty and Pathologic Outcomes

Yazici S., Inci K., Yuksel S., BİLEN C. Y., Ozen H.

UROLOGY , cilt.73, sa.4, ss.856-859, 2009 (SCI-Expanded, Scopus)

64. Laparoscopic pyeloplasty: evaluation of 27 cases

Inci K., GÜDELOĞLU A., YAZICI M. S., ERGEN A., BİLEN C. Y.

TURKISH JOURNAL OF UROLOGY , cilt.35, sa.1, ss.11-16, 2009 (ESCI, Scopus, TRDizin)

65. Port Site and Local Recurrence of Incidental Solitary Renal Plasmacytoma After Retroperitoneoscopic Radical Nephrectomy

Yazici S., Inci K., Dikmen A., ERGEN A., BİLEN C. Y.

UROLOGY , cilt.73, sa.1, 2009 (SCI-Expanded, Scopus)

66. Bilateral testicular germ cell tumors in Turkey: Increase in incidence in last decade and evaluation of risk factors in 30 patients

Bulent A., Taner D. R., Tolga T., Sertac Y., Celik T., Ferruh Z., et al.

JOURNAL OF UROLOGY , cilt.178, sa.1, ss.129-133, 2007 (SCI-Expanded, Scopus)

67. Therapy of multidrug resistant human prostate tumors in the prostate of nude mice by simultaneous targeting of the epidermal growth factor receptor and vascular endothelial growth factor receptor on tumor-associated endothelial cells

Busby J. E., Kim S., Yazici S., Nakamura T., Kim J., He J., et al.

PROSTATE , cilt.66, sa.16, ss.1788-1798, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

68. Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancer

Kim S., Uehara H., Yazici S., Busby J. E., Nakamura T., He J., et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE , cilt.98, sa.11, ss.783-793, 2006 (SCI-Expanded, Scopus)

69. Treatment delay and prognosis in invasive bladder cancer

Liedberg F., Anderson H., Mansson W., YAZICI M. S.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.5, sa.1, ss.21-22, 2006 (ESCI, TRDizin) Sürdürülebilir Kalkınma

70. Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice

Yazici S., Kim S., Busby J., He J., Thaker P., Yokoi K., et al.

PROSTATE , cilt.65, sa.3, ss.203-215, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

71. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T-1 breast cancer

Cabioglu N., Yazici M. S., Arun B., Broglio K., Hortobagyi G., Price J., et al.

CLINICAL CANCER RESEARCH , cilt.11, sa.16, ss.5686-5693, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

72. Induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice

Yokoi K., Kim S., Thaker P., Yazici S., Nam D., He J., et al.

NEOPLASIA , cilt.7, sa.7, ss.696-704, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

73. Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors

Thaker P., Yazici S., Nilsson M., Yokoi K., Tsan R., He J., et al.

CLINICAL CANCER RESEARCH , cilt.11, sa.13, ss.4923-4933, 2005 (SCI-Expanded, Scopus)

74. Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer

Kim S., Uehara H., Yazici S., He J., Langley R., Mathew P., et al.

CANCER RESEARCH , cilt.65, sa.9, ss.3707-3715, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

75. Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model

Yokoi K., Thaker P., Yazici S., Rebhun R., Nam D., He J., et al.

CANCER RESEARCH , cilt.65, sa.9, ss.3716-3725, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

76. Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice

Lev D., Kim S., Onn A., Stone V., Nam D., Yazici S., et al.

CLINICAL CANCER RESEARCH , cilt.11, sa.1, ss.306-314, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

77. Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice

Kim S., Uehara H., Yazici S., Langley R., He J., Tsan R., et al.

CANCER RESEARCH , cilt.64, sa.12, ss.4201-4208, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

78. Effect of periprostatic nerve blockade before transrectal ultrasound-guided prostate biopsy on patient comfort: A randomized placebo controlled study

Inal G., Yazici S., Adsan O., Ozturk B., Kosan M., Cetinkaya M.

INTERNATIONAL JOURNAL OF UROLOGY , cilt.11, sa.3, ss.148-151, 2004 (SCI-Expanded, Scopus)

79. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA

Ozden C., Inal G., Adsan O., Yazici S., Ozturk B.

UROLOGIA INTERNATIONALIS , cilt.71, sa.2, ss.150-153, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 20

1. Telerehabilitation-Based versus Face-to-Face Pelvic Floor Muscle Training in Male Urinary Incontinence Following Radical Prostatectomy: A Randomized Clinical Trial

Atabey Gerlegiz E. N., Akbayrak T., Gürşen C., Mangır Bolat N., Gülören G., Çinar G. N., et al.

ICS 2024, Madrid, İspanya, 24 Ekim 2024, (Özet Bildiri)

2. PSYCHOMETRIC PROPERTIES OF SCREENING INSTRUMENTS FOR PSORIATIC ARTHRITIS

Ozdede A., AYAN G., CAN G., Bektas M., Akdogan N., Solak E. O., et al.

European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1796-1797, (Özet Bildiri)

3. ADDING KNACK MANOEUVRE AND LIFESTYLE RECOMMENDATIONS TO PELVIC FLOOR MUSCLE TRAINING FOR POST-PROSTATECTOMY URINARY INCONTINENCE: A RANDOMIZED CONTROLLED TRIAL

Gerlegiz E. N., Akbayrak T., Gursen C., Mangir N., Yazici S., Akdogan B., et al.

52nd Annual Meeting of the International Continence Society (ICS 2022), Vienna, Avusturya, 7 - 10 Eylül 2022, cilt.2, sa.100354, ss.288-289, (Özet Bildiri)

4. Prostatektomi sonrası üriner inkontinans semptomu olan bireylerde multimodal fizyoterapi programı ile pelvik taban kas eğitiminin etkilerinin karşılaştırılması: ön çalışma

ATABEY E. N., AKBAYRAK T., GÜRŞEN C., MANGIR N., YAZICI M. S., NAKİP G., et al.

7. Ulusal İşlevsel Üroloji ve Kadın Ürolojisi Kongresi, Türkiye, 20 Ekim 2021, (Özet Bildiri)

5. Stereotactic Body Radiotherapy in Prostate Cancer: A Single Center Experience

AKYOL H. F., HÜRMÜZ P., YÜCE SARI S., Doğan Elmalı A., YÜCE D., YAZICI M. S., et al.

38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), 24 - 30 Nisan 2019, cilt.133, ss.828, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

6. EXAMINATION OF FORMAL THOUGHT DISORDER AND ITS CLINICAL CORRELATES WITH THE TURKISH VERSION OF THE THOUGHT AND LANGUAGE DISORDER SCALE (TALD-TR) IN SCHIZOPHRENIA

Mutlu E., YAZICI M. S., BARIŞKIN E., ERTUĞRUL A., GÜREL Ş. C., Gurkan S., et al.

Congress of the Schizophrenia-International-Research-Society (SRIS), Florida, Amerika Birleşik Devletleri, 10 - 14 Nisan 2019, cilt.45, (Özet Bildiri)

7. FACTORS AFFECTING POSITIVITY OF GA-68-PSMA PET/CT IN RECURRENCE OF LOCALIZED PROSTATE CANCER FOLLOWING DEFINITIVE THERAPY

Aydin A., Haberal B., Artykov M., Hazir B., Akdogan B., Bilen C., et al.

American-Urological-Association(AUA) Annual Meeting, San-Francisco, Kostarika, 18 - 21 Mayıs 2018, cilt.199, (Özet Bildiri) Sürdürülebilir Kalkınma

8. PROSTAT KANSERİNİN DEFİNİTİF TEDAVİSİ SONRASI REKÜRRENSİNDE GA-68-PSMA PET/BT POZİTİFLİK ORANI VE ETKİ EDEN FAKTÖRLER

AYDIN A. M., HABERAL H. B., Artykov M., AKDOĞAN B., GÜDELOĞLU A., BİLEN C. Y., et al.

13. Üroonkoloji Kongresi, Türkiye, 8 - 12 Kasım 2017

9. GA-68 PSMA PET/BT’xxNİN PROSTAT KANSERİ LENF NODU EVRELEMESİNDEKİ ETKİNLİĞİ: ERKEN DÖNEM SONUÇLAR

AYDIN A. M., HABERAL H. B., Artykov M., AKDOĞAN B., GÜDELOĞLU A., BİLEN C. Y., et al.

13. Üroonkoloji Kongresi, Türkiye, 8 - 12 Kasım 2017 Sürdürülebilir Kalkınma

10. RENAL TRANSPLANTASYON ÖNCESİ HASTA DEĞERLENDİRMESİ: LUMİNEX CROSS-MATCH’İN YERİ

TONYALI Ş., YILDIRIM T., HABERAL H. B., YAZICI M. S., YILMAZ Ş. R., ERDEM Y., et al.

6.Ulusal Transplantasyon İmmünolojisi ve Genetiği Kongresi, Türkiye, 6 - 09 Nisan 2017, (Özet Bildiri)

11. Adölesan döneminde seminom Bir olgu sunumu

KALKAN N., YALÇIN B., YAZICI M. S., BAYDAR D., AKYÜZ C.

XIX. TPOG Ulusal Pediatrik Kanser Kongresi, İzmir, Türkiye, 4 - 08 Mayıs 2016, (Özet Bildiri)

12. The Dosimetric Impact of Implants on the Spinal Cord Dose in Stereotactic Body Radiation Therapy

YAZICI G., Yedekci Y., Yucekul A., Birgi S., Demirkiran G., GÜLTEKİN M., et al.

56th Annual Meeting of the American-Society-for-Radiation-Oncology, San-Francisco, Kostarika, 14 - 17 Eylül 2014, cilt.90, (Özet Bildiri)

13. Temporal changes in the survival of metastatic renal cell cancer patients and the impact of targeted agents: Single center experience

Erman M., Arik Z., Kilickap S., Bilen C. Y., Yazici S., Akdogan B., et al.

Genitourinary Cancers Symposium, San-Francisco, Kostarika, 30 Ocak - 01 Şubat 2014, cilt.32, (Özet Bildiri) Sürdürülebilir Kalkınma

14. IS INTERMITTENT DOCETAXEL CHEMOTHERAPY REASONABLE IN HORMONE REFRACTORY PROSTATE CANCER? A PILOT RANDOMIZED STUDY

Akdogan B., Yazici S., Kirdal Y., Inci K., Erman M., Ozen H.

104th Annual Meeting of the American-Urological-Association, Illinois, Amerika Birleşik Devletleri, 25 - 30 Nisan 2009, cilt.181, ss.233, (Özet Bildiri) Sürdürülebilir Kalkınma

15. PROTEASOME INHIBITOR BORTEZOMIB INCREASES RADIATION SENSITIVITY IN ANDROGEN INDEPENDENT HUMAN PROSTATE CANCER CELLS

Goktas S., Ural A. U., Baran Y., Yazici S., Aydur E., Avcu F., et al.

104th Annual Meeting of the American-Urological-Association, Illinois, Amerika Birleşik Devletleri, 25 - 30 Nisan 2009, cilt.181, ss.98, (Özet Bildiri)

16. A new device for the treatment of post-prostatectomy incontinence: Adjustable perineal male sling

Inci K., Ergen A., Yazici S., Bilen C. Y., Kara O., Ozen H.

103rd Annual Meeting of the American-Urological-Association, Florida, Amerika Birleşik Devletleri, 17 Mayıs 2008, cilt.179, ss.515, (Özet Bildiri)

17. In vivo imaging of luciferase-labeled human prostate cancer cells, pc-3mm2, in orthotopic nude mouse models

Yazici S., Busby E., Kim S. J., Fidler I. J.

103rd Annual Meeting of the American-Urological-Association, Florida, Amerika Birleşik Devletleri, 17 Mayıs 2008, cilt.179, ss.425, (Özet Bildiri) Sürdürülebilir Kalkınma

18. The predictive role of clinicopathological parameters and cell cycle regulatory proteins (p53, ki67 and bcl-2) in biochemical relapse after radical prostatectomy (RP) in intermediate and high risk group. A tissue microarray study.

Baseskioglu B. A., Baydar D. E., Akduman B., Yazici S., DeMarzo A. M., Ozen H.

102nd Annual Meeting of the American-Urological-Association, California, Amerika Birleşik Devletleri, 19 - 24 Mayıs 2007, cilt.177, ss.376, (Özet Bildiri)

19. Bypass of drug resistance by antivascular therapy with protein tyrosine kinase inhibitor, STI571, in a human prostate cancer bone metastasis model of nude mice

Kim S., Yazici S., Uehara H., Busby J., He J., Fan D., et al.

4th North American Symposium on Skeleted Complications of Malignancy, Maryland, Amerika Birleşik Devletleri, 28 - 30 Nisan 2005, cilt.20, (Özet Bildiri) Sürdürülebilir Kalkınma

20. Inhibition of platelet-derived growth factor receptor restricts the growth of breast cancer cells in the bone but not in the mammary fatpad

Lev D., Kim S., Onn A., Stone V., Nam D., Yazici S., et al.

4th International Conference on Cancer-Induced Bone Diseases, San-Antonio, Kuzey Mariana Adaları, 08 Aralık 2003, cilt.19, ss.1579, (Özet Bildiri) Sürdürülebilir Kalkınma

Kitaplar 2

1. Preserving fertility in patients with gastrointestinal cancers

tunali d., oguz s. y., SELEK U., BALIK E., tonyali s., YAZICI M. S.

Textbook of Gastrointestinal Oncology, Suayip Yalcin, Philip A Philip, Editör, Springer, ss.633-654, 2019

2. Twenty Years and Counting: Is PSA Still Useful in 2010?

Yazıcı M. S.

Management of Prostate Cancer, E.A. Klein,J.S. Jones, Editör, Humana Press, Inc. , New-York, ss.13-24, 2012

Metrikler

Yayın

110

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

937

H-İndeks (WoS)

Atıf (Scopus)

1021

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Tez Danışmanlığı

Açık Erişim